David Inman

United States Surgical Corp. engages in the manufacture of wound closure products and surgical devices. It produces tools used in surgery including staplers, sutures, laparoscopic instruments, cardiovascular surgical products and electrosurgical devices. The company was founded in 1964 and is headquartered in North Haven, CT.

EndoGastric Solutions, Inc. develops natural orifice surgical products and procedures to advance the treatment of gastrointestinal diseases. The firm offers EsophyX device and StomaphyX device. The company was founded by Stefan J. M. Kraemer, Clifton A. Alferness, Scott Jordan Wolf, James W. Fitzsimmons and John M. Adams in 2003 and is headquartered in Redmond City, WA.

Augmenix, Inc. develops hydrogel technology to improve outcomes in radiation oncology and surgery. Its products include TraceIT Tissue Marker and SpaceOAR System, which is an absorbable hydrogel spacer that reduces radiation injury to the rectal wall in men undergoing prostate radiotherapy. The company was founded by Amarpreet S. Sawhney in 2008 and is headquartered in Bedford, MA.

Thesan Pharmaceuticals, Inc. provides novel therapeutics for disorders of the skin. The company focuses on the discovery and development of new chemical entities that provide improved treatment options to patients. Thesan Pharmaceuticals was founded in 2011 by Edward P. Monaghan and is headquartered in Carlsbad, CA.

McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY.

Lundbeckfond Invest A/S (Lundbeckfond Invest) is the investment management subsidiary of the Lundbeck Foundation in Denmark. Established in 1999, the firm is based in Copenhagen and manages the Lundbeck Foundation's investments, aiming for long-term, stable returns with moderate risk, such that the Foundation's net capital is not jeopardized and the Foundation is able to meet its commitments in terms of awarding grants and of laying a capital base for its subsidiaries.

Clinical Innovations Europe Ltd. manufactures healthcare products for infants. It offers bayLance safety heelsticks, traxi Panniculus Retractor, ROM Plus Rupture of Membrane tests, edd Complete Tamponade System, Kiwi complete Vacuum Delivery System, Koala IUPC, and ClearView Uterine Manipulator. The company was founded in 1993 and is headquartered in Heathrow, the United Kingdom.

Symbion A/S provides office communities, meeting facilities, conference facilities, business development and capital for start-up companies. The company was founded in 1986 and is headquartered in Copenhagen, Denmark.

TranS1, Inc. designs and develops surgical procedures and equipment for back pain. It is a medical device company focused on designing, developing and marketing products that implement its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region. TranS1 currently markets the AxiaLIF family of products for single-level and two-level lumbar fusion and the Vectre and Avatar posterior fixation systems for lumbar fixation supplemental to AxiaLIF fusion. Its primary technology is AxiaLIF, a minimally invasive access and fusion system that enables lumbar fusion to be performed with complete preservation of the annulus and all paraspinal soft tissue structures. The company specializes in bringing innovative spine solutions to market, including AxiaLIF and AxiaLIF 2L+, technologies that allow surgeons to perform lower lumbar fusions that result in high fusion rates and low complication rates. The company is also developing a motion preservation platform to be delivered through this minimally invasive, trans-sacral approach. TranS1 was founded in May 2000 and is headquartered in Wilmington, NC.

Clinical Innovations LLC develops, manufactures and markets medical devices. It products include traxi Panniculus Retractor, ROM Plus Rupture of Membranes Test, ebb Complete Tamponade System, Koala Toco, Kiwi Complete Vacuum Delivery System, Koala IUPC, ClearView Uterine Manipulator and C-Snorkel Impacted Fetal Head Release. The company was founded in 1993 and is headquartered in Murray, UT.

7TM A/S performs research and development within biotechnology. It engages in clinical development of drugs focusing on obesity and gastrointestinal diseases. The company was founded by Thue Walter Schwartz, Anders Fink Vadsholt, Mette Kirstine Agger, Christian Ellebæk Elling, and Peter Moldt on January 1, 2000 and is headquartered in Hørsholm, Denmark.

Advanced Medical Technology Association is a trade association which provides medical technology solutions. The company was founded in 1974 and is headquartered in Washington, DC.

Covidien Unlimited Co. engages in the development, manufacture, and sale of healthcare products for use in clinical and home settings. It operates through Medical Devices and U.S. Medical Supplies segments. The Medical Devices segment involves in the distribution of surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. The U.S. Medical Supplies segment includes marketing of nursing care, medical surgical, SharpSafety brand, and original equipment manufacturer (OEM) products. The company was founded in 1967 and is headquartered in Dublin, Ireland.

AlloCure, Inc. develops cell therapies for the treatment of kidney diseases. It engages in developing allogeneic mesenchymal stem cell therapy for acute kidney injury. The company was founded in 2008 and is headquartered in Burlington, MA.

Lundbeckfonden Ventures (Lundbeckfonden Ventures) is a venture capital firm wholly-owned by the Lundbeck Foundation. The firm was established in 2009 and is headquartered in Copenhagen, Denmark.

Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom.

Bioventus LLC is a holding company, which manufactures medical equipment. It develops bone healing devices and distributes osteoarthritis injection therapies. Its products include ultrasound bone healing device, joint therapies, and osteoarthritis injection therapies. The company was founded in 2012 and is headquartered in Durham, NC.

The Institute of Occupational Medicine conducts research on stress and psychosocial issues to promote safer and healthier living. The non-profit company is based in Edinburgh, UK, and was founded in 1969. The British company provides health and safety solutions to various sectors in the UK, including industry, commerce, public sector, and professional bodies. The company specializes in workplace health research and consultancy services, with expertise in various scientific disciplines such as policy evaluations and treatment room ventilation. The CEO is Rob Aitken.

Part of Advanced Medical Technology Association, AdvaMed Accel operates as a medical technology association. The company is based in Washington. The CEO of the American company is Mark A. Augusti.

NeoLight LLC provides technology solutions. The company was founded by Vivek Kopparthi, Chase Garrett and Sivakumar Palaniswamy and is headquartered in Scottsdale, AZ.

VarmX BV is a spin-off from Leiden University Medical Center (LUMC) founded in 2016 by Professor Pieter Reitsma, a world-leading expert in hemostasis and thrombosis. VarmX is based in Leiden, NL. The Dutch company's lead compound, VMX-C001, is a modified recombinant blood factor X developed for the treatment of severe spontaneous bleeding and for the prevention of bleeding during urgent surgery in patients taking oral factor Xa inhibitors (FXa DOACs) as anticoagulation therapy. The company is supported by a strong syndicate of investors. Jan K. Öhrström has been the CEO of the company since 2018.

Ossio, Inc. is an orthopedic fixation company. It provides replacement to metal implants in the orthopedic fixation market (screws, pins, plates) with an Intelligent Bone Regeneration Technology. The company was founded by Orahn Preiss-Bloom in 2014 and is headquartered in Woburn, MA.

Rejoni, Inc. engages in the provision of biotechnology services. It focuses on developing products that improve the outcomes of minimally invasive and other gynecological surgical procedures. The company was founded in June 2020 and is headquartered in Bedford, MA.

Breye Therapeutics ApS is a biopharmaceutical company based in Copenhagen, Denmark. The Danish company develops novel, oral ophthalmology drugs to address the needs of millions of patients suffering from deteriorating vision due to diabetic retinopathy (DR) or age-related macular degeneration (AMD). Breye Therapeutics' lead program with Danegaptide has a clinically de-risked safety profile and potential for a short and well-accepted clinical regulatory pathway. The company aims to provide less burdensome and more effective treatments for DR and AMD patients, which are currently treated with unpopular intravitreal injections directly into the eye. The company was founded in 2019, and the CEO is Ulrik Mouritzen.